Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kwality Pharmaceuticals
Amritsar, Punjab, Indiakwalitypharma.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Kwality Pharmaceuticals has a strong commercial portfolio of over 600 registered products globally and a robust pipeline of complex injectables, biosimilars, and niche generics. The company recently achieved proof of concept for its first biosimilar (erythropoietin), with biosimilar etanercept and alteplase in development. They are leaders in small molecules and advanced injectable technologies, with recent approvals expanding their international market reach, especially in Latin America and regulated markets[2][5][8][6].
- Therapeutic areas
- OncologyHematologyImmunologyCardiovascular
- Modalities
- Small moleculePeptidesProteinLiposomal formulationMicrospheresRecombinant proteinBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Kwality Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kwality Pharmaceuticals.